Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "financial results" return 52 results.
Ceva continues rapid growth in 2011 >
Twin pillar strategy of combining internal and external growth opportunities drives further global expansion
Second joint Human and Veterinary Cardiology Symposium >
Together for health, in the heart of Bordeaux
Ceva acquires Vetech Laboratories, Inc. >
Move adds significant poultry vaccine to innovative portfolio
Nomination : Corporate Marketing Directors - 13th July 2010 >
Ceva reinforces the management of its marketing organisation with the recruitment of two key executives
USA: Ceva acquires Summit VetPharm, LLC - 26th August 2010 >
LENEXA, Kan.— Ceva, a global veterinary pharmaceutical group, is pleased to announce the company has entered into an agreement with Sumitomo Corporation of America, and Sumitomo Corporation, to acquir...
Our Management Team >
The Executive Committee is above all a team, which considers the major issues facing the group, and then makes decisions including the most difficult ones, in a frank and ethical way.
Salmonella >
The regular monitoring of Salmonella in poultry is obligatory in many countries in Europe and the Americas. Salmonella Enteritidis is the cause of food-borne infections via faecal contamination or mor...
Questions >
Frequently asked questions
Ceva Biovac Mycoplasma >
Mycoplasma are very small bacteria (between 0.3 and 0.8 μm in diameter) characterised by the absence of cell wall.
Practical information >
Autogenous vaccines: practical information